English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Bio-Manguinhos / Fiocruz has been leading original and follow-on biologics joint development and technology transfer processes in order to attend the increasing demand of the Ministry of Health. Alongside this, new challenges have arisen: the establishment of new regulatory standards for pharmacovigilance due to the concern regarding risk-benefit ratio of biologics and the increasing range of social media that can be used to disseminate unreliable information that can jeopardize health programs. Pharmacovigilance is defined as the science and activities relating to detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.

Current challenge in pharmacovigilance at Bio-Manguinhos/Fiocruz: detection of drug related problems in social media